Achieving Cell-Selective Delivery to Maximize Efficacy & Minimize Systemic Toxicity

9:30 am - Wednesday 2nd December 2026

  • Design principles for targeted delivery approaches
  • Leveraging fibroblast-selective targeting to concentrate drug exposure in target cells/tissue
  • Balancing the complexity of targeted delivery with the therapeutic benefit & competitive differentiation

Speakers:

Senior Principal Scientist
Novartis AG